# Delta Contributes to National Advocacy Effort Supporting Hemp Beverage Regulation > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/delta-contributes-to-national-advocacy-effort-supporting-hemp-beverage-regulation/ > **Published:** 2026-05-21T18:55:23-04:00 | **Last Modified / Clinically Audited:** 2026-09-27T21:51:13-04:00 > **Clinical Summary:** Hemp beverage regulation efforts aim to standardize labeling and testing. What clinicians need to know about dosing safety. --- ✦ New CED Clinical Relevance #35 [Clinical Context](https://cedclinic.com/cannabis-hyperemesis-syndrome-treatment-insights-2026/) Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape. PolicyHempIndustryDosingSafetyAgingRegulation Clinical Summary # Summary Delta’s participation in national advocacy for hemp beverage regulation reflects growing industry efforts to establish standardized safety and labeling requirements for cannabis-infused beverages, a product category expanding rapidly in the consumer market. Hemp beverages, which may contain variable concentrations of cannabinoids including delta-8 and delta-10 THC, currently operate in a largely unregulated space where potency labeling and contamination standards are inconsistent across jurisdictions. Clinicians should recognize that patients increasingly encounter these products through retail channels and word-of-mouth recommendations without reliable dosing information or quality assurance, creating potential for unintended overconsumption or exposure to unlabeled adulterants. Formalized beverage regulation could improve product transparency and consistency, though clinicians should remain cautious about cannabinoid products lacking rigorous clinical safety data in their respective patient populations. For [clinical practice](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/), physicians should actively inquire about beverage consumption patterns when assessing [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/), recognizing these products as a significant and growing route of patient exposure that currently lacks standardized medical guidance on safe dosing or appropriate patient populations. Dr. Caplan’s Take “The lack of standardized dosing in hemp beverages represents a genuine clinical problem, particularly for older adults who may be taking multiple medications and have narrow therapeutic windows, so I support regulatory frameworks that establish clear labeling and consistent potency standards.” Clinical Perspective As cannabis products become increasingly available in beverage formats, clinicians should be aware that industry advocacy efforts are shaping the regulatory landscape for these emerging products. The participation of major cannabis companies in national hemp beverage regulation discussions reflects both genuine safety considerations and commercial interests in market expansion, making it important for providers to recognize potential bias in industry-generated information. Given that edible cannabis products, including beverages, present unique pharmacokinetic challenges (delayed onset, prolonged duration, variable absorption) compared to inhaled forms, the regulatory framework will likely influence how and whether patients encounter these products. The current trend of older adults adopting [cannabis edibles](https://cedclinic.com/decarboxylating-cannabis-process-why-how/) based on peer recommendations rather than medical guidance suggests that clinical education gaps remain significant. Providers should proactively discuss cannabis beverage use with patients, particularly older adults, to understand consumption patterns, assess potential drug interactions, and provide evidence-based guidance on dosing and risks, regardless of how these products become regulated at the 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Delta%20Contributes%20to%20National%20Advocacy%20Effort%20Supporting%20Hemp%20Beverage%20Regulation%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D55998)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D55998)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Delta%20Contributes%20to%20National%20Advocacy%20Effort%20Supporting%20Hemp%20Beverage%20Regulation%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D55998)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) 📰 Source: [https://www.cannabisequipmentnews.com/news/news/22967319/delta-contributes-to-national-advocacy-effort-supporting-hemp-beverage-regulation](https://www.cannabisequipmentnews.com/news/news/22967319/delta-contributes-to-national-advocacy-effort-supporting-hemp-beverage-regulation) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).